Skip to main content
Caplight Logo









Journey Clinical

Journey Clinical

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.journeyclinical.com/

Last Round

Series A

Jan 24, 2023

Total Funding Raised

$11.5M

Company Overview

Journey Clinical is a healthtech company that provides a platform for licensed mental health professionals to deliver Psychedelic-Assisted Psychotherapy (PAP), starting with Ketamine-Assisted Psychotherapy (KAP).

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Vertical SaaS, Telemedicine

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

ketamine-assisted psychotherapyKAPpsychedelic-assisted therapymental health platformvertical SaaStelemedicineclinical infrastructureHIPAA-compliant platformbehavioral healththerapist trainingpractice managementpsychedelic medicinemedical oversightB2B2CAI clinical scribe

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Journey Clinical Comparables

Compare Journey Clinical with similar companies based on industry and business-model similarity.

Journey Clinical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Osmind
72%
Althea
70%
Fluence
69%

Journey Clinical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 24, 2023
SeedSep 30, 2021

Key People

Founding team and executive leadership

Myriam Barthes

Co-Founder & CEO

Founding Team

Journey Clinical Investors

Notable investors and investment history

Journey Clinical investors
InvestorRounds
AlleyCorpSeries A
Able PartnersSeries A
Union Square VenturesSeries A
GaingelsSeries A
Lionheart VenturesSeed
Mystic VenturesSeries A
Palo SantoSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2025

    Offering in-person monitoring for Spravato® treatments.

  • Oct 15, 2025

    Will provide Ketamine-Assisted Psychotherapy (KAP) education for group members.

Journey Clinical Filings

Explore SEC and related filing metadata, where available.

Journey Clinical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Journey Clinical's valuation, stock price, and market status.

Is Journey Clinical a public or private company?

Journey Clinical is a private company.

What is the current stock price of Journey Clinical?

Journey Clinical is a private company with no public stock price. No recent secondary market data is available.

How much is Journey Clinical worth (valuation)?

Valuation information for Journey Clinical is not publicly available.

Can I buy Journey Clinical stock?

Journey Clinical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Journey Clinical's last funding round?

Journey Clinical's most recent funding round was Series A on January 24, 2023.

Who are the main investors in Journey Clinical?

Key investors in Journey Clinical include Union Square Ventures, Fifty Years.

Will Journey Clinical IPO soon?

No public IPO plans have been announced for Journey Clinical.

How can I track Journey Clinical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Journey Clinical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range76
Year Founded2020
Last FundingJan 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?